Sign in
Taking people in South KoreaNo phase

Exercise Capacity and Heart Blood Flow in Heart Failure With Preserved Ejection Fraction

Tests heart blood flow during stress and exercise in adults with suspected heart failure.

Key facts

Who runs it
Korea University Anam Hospital
Where
Seoul, South KoreaSee the site
Trial code
Registry title
Exercise Capacity According to Coronary Microvascular Dysfunction and Body Composition
Status
Recruiting
People taking part
100 people, planned
Started
15 Apr 2021
Planned end
31 Dec 2025
Type of study
Interventional
Treatments tested
  • Adenosine stress echocardiography with the evaluation of coronary artery blood flow
Record updated
2 September 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 20 to 80 with chest pain or breathlessness, no major coronary artery narrowing, and a heart pumping fraction of 50% or more.

Age
20 to 80 years
Sex
All sexes can join.
Disease stage
Typical or atypical chest pain or ischemic symptoms including dyspnea. No significant coronary artery stenosis (>50% stenosis) on angiography or CT. Left ventricular ejection fraction ≥50%.
Earlier treatment
People receiving anticancer drugs cannot join.

Main reasons for not taking part

  • More than moderate valvular heart disease
  • Congenital heart disease
  • Chronic renal failure (eGFR <30 ml/min/1.73m2) or end-stage renal failure on dialysis
  • Asthma, chronic obstructive pulmonary disease or primary pulmonary hypertension
  • Atrial fibrillation

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Age 20 to 80
  • Typical/atypical chest pain or ischemic symptoms including dyspnea
  • No significant coronary artery stenosis (>50% stenosis) in coronary angiography or computed tomography
  • Left ventricular ejection fraction ≥50%

Who cannot take part

  • Receiving anticancer drugs
  • More than moderate valvular heart disease
  • Congenital heart disease
  • Chronic renal failure (estimated glomerular filtration rate <30 ml/min/1.73m2) or end-stage renal failure undergoing hemodialysis or peritoneal dialysis
  • Asthma, chronic obstructive pulmonary disease and primary pulmonary hypertension
  • Vasculitis associated with autoimmune diseases
  • Atrioventricular block with more than second degrees, symptomatic bradycardia, cryo-node failure syndrome, Wolff-Parkinson-White (WPW) patients
  • Patients with difficulty in performing exercise load evaluation (treadmill, bicycle ergometer)
  • Atrial fibrillation

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 20 and 80 years old?

Where in South Korea

  • Korea University Anam HospitalSeoul, South KoreaContact: So Ree Kim, MDTaking people

About the trial

What the trial wants to find out

The correlation of coronary microvascular function and body composition with cardiopulmonary exercise capacity will be assessed in patients with heart failure with preserved ejection fraction.

The group in the trial

  • Heart failure with preserved ejection fractionOther group

    Adenosine stress echocardiography, body composition, and cardiopulmonary exercise test will be done in all of the enrolled patients. Left ventricular end-diastolic pressure will be assessed during coronary angiography.

    Treatment: Adenosine stress echocardiography with the evaluation of coronary artery blood flow

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Differences in Cardiopulmonary Exercise Capacity According to Coronary Microvascular Dysfunction and Body Composition in Patients With Suspected Heart Failure With Preserved Ejection Fraction
Plain-language title
Exercise Capacity and Heart Blood Flow in Heart Failure With Preserved Ejection FractionGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT04822649, who can take part
Publications
Record updated
2 September 2025